Literature DB >> 23593574

Subacute oral toxicity study of ethanolic leaves extracts of Strobilanthes crispus in rats.

Kean Tatt Lim1, Vuanghao Lim, Jin Han Chin.   

Abstract

OBJECTIVE: To examine the oral toxicity of repeated dosing of Strobilanthes crispus (S. crispus) ethanol leaves extract on the liver and kidney functions in Sprague Dawley rats.
METHODS: Young female rats aged between 8 and 12 week-old were randomly assigned into four groups with five animals each group (n=5). The first group served as control, while the second, third and fourth groups were orally treated with a single dose daily with 150 mg/kg, 300 mg/kg, and 600 mg/kg of S. crispus ethanol leaves extract for 14 d consecutively. Cage-side observation was conducted for first 4 h after each dosing. The body weight changes, food consumptions and water intake were also recorded. Serum biochemical parameters, i.e., aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, creatinine and urea were determined at Day 15. All results were expressed as mean±SD and analysed using Dunnett's test.
RESULTS: It was obtained that 14-day oral administration of S. crispus ethanol leaves extract did not cause any adverse effects or lethality to the female Sprague Dawley rats. No significant changes in serum biochemical parameters, relative organs weights, body weights, food intake and water consumptions were observed between the treatment groups and control.
CONCLUSIONS: In conclusion, 14-day oral administration of S. crispus ethanol leaves extract was safe to be consumed in female rats without affecting the liver and kidney functions.

Entities:  

Keywords:  Kidney; Liver; Oral toxicity; Serum enzymes; Strobilanthes crispus

Mesh:

Substances:

Year:  2012        PMID: 23593574      PMCID: PMC3621470          DOI: 10.1016/S2221-1691(13)60005-2

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  9 in total

1.  Predicting the active doses in humans from animal studies: a novel approach in oncology.

Authors:  M Rocchetti; M Simeoni; E Pesenti; G De Nicolao; I Poggesi
Journal:  Eur J Cancer       Date:  2007-07-02       Impact factor: 9.162

2.  Evaluation of statistical tools used in short-term repeated dose administration toxicity studies with rodents.

Authors:  Katsumi Kobayashi; K Sadasivan Pillai; Yuki Sakuratani; Takemaru Abe; Eiichi Kamata; Makoto Hayashi
Journal:  J Toxicol Sci       Date:  2008-02       Impact factor: 2.196

3.  Chemical composition and antioxidant activity of Strobilanthes crispus leaf extract.

Authors: 
Journal:  J Nutr Biochem       Date:  2000-11       Impact factor: 6.048

4.  Strobilanthes crispus attenuates renal carcinogen, iron nitrilotriacetate (Fe-NTA)-mediated oxidative damage of lipids and DNA.

Authors:  Mohammad Iqbal; Muhammad Dawood Shah; Chau Ann Lie; Chin Kim San
Journal:  Mol Cell Biochem       Date:  2010-04-08       Impact factor: 3.396

5.  Toxicity evaluation of a standardised 50% ethanol extract of Orthosiphon stamineus.

Authors:  Elsnoussi Ali Hussin Mohamed; Chung Pin Lim; Omar Saad Ebrika; Mohd Zaini Asmawi; Amirin Sadikun; Mun Fei Yam
Journal:  J Ethnopharmacol       Date:  2010-10-19       Impact factor: 4.360

6.  Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro.

Authors:  Nik Soriani Yaacob; Nurraihana Hamzah; Nik Nursyazni Nik Mohamed Kamal; Siti Amalina Zainal Abidin; Choon Sheen Lai; Visweswaran Navaratnam; Mohd Nor Norazmi
Journal:  BMC Complement Altern Med       Date:  2010-08-05       Impact factor: 3.659

7.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

Review 8.  Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo.

Authors:  Hans Lennernäs
Journal:  Adv Drug Deliv Rev       Date:  2007-08-22       Impact factor: 15.470

9.  Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin.

Authors:  Rosina Khan; Barira Islam; Mohd Akram; Shazi Shakil; Anis Ahmad; S Manazir Ali; Mashiatullah Siddiqui; Asad U Khan
Journal:  Molecules       Date:  2009-02-04       Impact factor: 4.411

  9 in total
  3 in total

1.  Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Mammary Tumour Model.

Authors:  Nik Soriani Yaacob; Hassan Muhammad Yankuzo; Sutha Devaraj; Jimmy Ka Ming Wong; Choon-Sheen Lai
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

2.  Preclinical safety assessment of Angelica acutiloba using a 13-week repeated dose oral toxicity study in rats.

Authors:  Jun-Won Yun; Euna Kwon; Seung-Hyun Kim; Ji-Ran You; Yun-Soon Kim; In Ae Park; Hyeon Hoe Kim; Jeong-Hwan Che; Byeong-Cheol Kang
Journal:  Lab Anim Res       Date:  2017-09-27

3.  Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats.

Authors:  Jun-Won Yun; Euna Kwon; Yun-Soon Kim; Seung-Hyun Kim; Ji-Ran You; Hyoung-Chin Kim; Jin-Sung Park; Jeong-Hwan Che; Sang-Koo Lee; Ja-June Jang; Hyeon Hoe Kim; Byeong-Cheol Kang
Journal:  BMC Complement Altern Med       Date:  2018-09-12       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.